tirzepatide 15mg pen MOUNJARO 15 MG / 0.5 ML ( ) FOR SUBCUTANEOUS INJECTION 4 PRE-FILLED PENS Mounjaro® KwikPen® 15mg (1 Pen)

GLP-1s arent ready to be used to address any psychiatric condition

This dual mechanism makes it valuable for research spanning both metabolic GH biology and cardiac physiology

The objective was to evaluate the effectiveness and safety, with a specific focus on cardiovascular safety, of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, compared to insulin glargine in adults with type 2 diabetes and a high risk of cardiovascular events who have not achieved adequate control with oral glucose-lowering medications.This phase 3 study was conducted at 187 sites across 14 countries on five continents

Acta bio-medica : Atenei Parmensis